FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110453313> ?p ?o ?g. }

• W2110453313 endingPage "4888" @default.
• W2110453313 startingPage "4879" @default.
• W2110453313 abstract "Abstract Purpose: Tumor hypoxia is associated with a poor prognosis, hypoxia modification improves outcome, and hypoxic status predicts benefit from treatment. Yet, there is no universal measure of clinical hypoxia. The aim of this study was to investigate whether a 26-gene hypoxia signature predicted benefit from hypoxia-modifying treatment in both cancer types. Experimental Design: Samples were available from 157 T2–T4 laryngeal cancer and 185 T1–T4a bladder cancer patients enrolled on the accelerated radiotherapy with carbogen and nicotinamide (ARCON) and bladder carbogen nicotinamide (BCON) phase III randomized trials of radiotherapy alone or with carbogen and nicotinamide (CON) respectively. Customized TaqMan low density arrays (TLDA) were used to assess expression of the 26-gene signature using quantitative real-time PCR. The median expression of the 26 genes was used to derive a hypoxia score (HS). Patients were categorized as TLDA-HS low (≤median) or TLDA-HS high (&gt;median). The primary outcome measures were regional control (RC; ARCON) and overall survival (BCON). Results: Laryngeal tumors categorized as TLDA-HS high showed greater benefit from ARCON than TLDA-HS low tumors. Five-year RC was 81% (radiotherapy alone) versus 100% (CON) for TLDA-HS high (P = 0.009). For TLDA-HS low, 5-year RC was 91% (radiotherapy alone) versus 90% (CON; P = 0.90). TLDA-HS did not predict benefit from CON in bladder cancer. Conclusion: The 26-gene hypoxia signature predicts benefit from hypoxia-modifying treatment in laryngeal cancer. These findings will be evaluated in a prospective clinical trial. Clin Cancer Res; 19(17); 4879–88. ©2013 AACR." @default.
• W2110453313 created "2016-06-24" @default.
• W2110453313 creator A5001440760 @default.
• W2110453313 creator A5012052834 @default.
• W2110453313 creator A5020453607 @default.
• W2110453313 creator A5030694212 @default.
• W2110453313 creator A5043961512 @default.
• W2110453313 creator A5051708028 @default.
• W2110453313 creator A5059592907 @default.
• W2110453313 creator A5072265839 @default.
• W2110453313 creator A5075865182 @default.
• W2110453313 creator A5079330516 @default.
• W2110453313 creator A5079633934 @default.
• W2110453313 creator A5079894409 @default.
• W2110453313 creator A5085289091 @default.
• W2110453313 creator A5089242256 @default.
• W2110453313 creator A5090664851 @default.
• W2110453313 date "2013-09-01" @default.
• W2110453313 modified "2023-10-10" @default.
• W2110453313 title "A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer" @default.
• W2110453313 cites W1967202761 @default.
• W2110453313 cites W1968428572 @default.
• W2110453313 cites W1998676371 @default.
• W2110453313 cites W2013080898 @default.
• W2110453313 cites W2014695629 @default.
• W2110453313 cites W2016052287 @default.
• W2110453313 cites W2031399619 @default.
• W2110453313 cites W2053662954 @default.
• W2110453313 cites W2064419187 @default.
• W2110453313 cites W2071143412 @default.
• W2110453313 cites W2071335476 @default.
• W2110453313 cites W2084116712 @default.
• W2110453313 cites W2084341371 @default.
• W2110453313 cites W2087604644 @default.
• W2110453313 cites W2091894720 @default.
• W2110453313 cites W2094233758 @default.
• W2110453313 cites W2098134455 @default.
• W2110453313 cites W2100616230 @default.
• W2110453313 cites W2100961085 @default.
• W2110453313 cites W2107277218 @default.
• W2110453313 cites W2113344831 @default.
• W2110453313 cites W2125675894 @default.
• W2110453313 cites W2128985829 @default.
• W2110453313 cites W2136800292 @default.
• W2110453313 cites W2145331736 @default.
• W2110453313 cites W2154981748 @default.
• W2110453313 cites W2160377567 @default.
• W2110453313 cites W2160450758 @default.
• W2110453313 cites W2163763232 @default.
• W2110453313 doi "https://doi.org/10.1158/1078-0432.ccr-13-0542" @default.
• W2110453313 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3797516" @default.
• W2110453313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23820108" @default.
• W2110453313 hasPublicationYear "2013" @default.
• W2110453313 type Work @default.
• W2110453313 sameAs 2110453313 @default.
• W2110453313 citedByCount "183" @default.
• W2110453313 countsByYear W21104533132013 @default.
• W2110453313 countsByYear W21104533132014 @default.
• W2110453313 countsByYear W21104533132015 @default.
• W2110453313 countsByYear W21104533132016 @default.
• W2110453313 countsByYear W21104533132017 @default.
• W2110453313 countsByYear W21104533132018 @default.
• W2110453313 countsByYear W21104533132019 @default.
• W2110453313 countsByYear W21104533132020 @default.
• W2110453313 countsByYear W21104533132021 @default.
• W2110453313 countsByYear W21104533132022 @default.
• W2110453313 countsByYear W21104533132023 @default.
• W2110453313 crossrefType "journal-article" @default.
• W2110453313 hasAuthorship W2110453313A5001440760 @default.
• W2110453313 hasAuthorship W2110453313A5012052834 @default.
• W2110453313 hasAuthorship W2110453313A5020453607 @default.
• W2110453313 hasAuthorship W2110453313A5030694212 @default.
• W2110453313 hasAuthorship W2110453313A5043961512 @default.
• W2110453313 hasAuthorship W2110453313A5051708028 @default.
• W2110453313 hasAuthorship W2110453313A5059592907 @default.
• W2110453313 hasAuthorship W2110453313A5072265839 @default.
• W2110453313 hasAuthorship W2110453313A5075865182 @default.
• W2110453313 hasAuthorship W2110453313A5079330516 @default.
• W2110453313 hasAuthorship W2110453313A5079633934 @default.
• W2110453313 hasAuthorship W2110453313A5079894409 @default.
• W2110453313 hasAuthorship W2110453313A5085289091 @default.
• W2110453313 hasAuthorship W2110453313A5089242256 @default.
• W2110453313 hasAuthorship W2110453313A5090664851 @default.
• W2110453313 hasBestOaLocation W21104533131 @default.
• W2110453313 hasConcept C104317684 @default.
• W2110453313 hasConcept C121608353 @default.
• W2110453313 hasConcept C126322002 @default.
• W2110453313 hasConcept C142724271 @default.
• W2110453313 hasConcept C143998085 @default.
• W2110453313 hasConcept C150194340 @default.
• W2110453313 hasConcept C173622453 @default.
• W2110453313 hasConcept C178790620 @default.
• W2110453313 hasConcept C185592680 @default.
• W2110453313 hasConcept C2779733811 @default.
• W2110453313 hasConcept C2780352672 @default.
• W2110453313 hasConcept C509974204 @default.
• W2110453313 hasConcept C540031477 @default.
• W2110453313 hasConcept C55493867 @default.

• next